
JPXBasic MaterialsChemicals - Specialty
أحدث البيانات المتاحة
1,458 JP¥
+18.00 JP¥ · +1.25%
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
أحدث البيانات المتاحة
1,458 JP¥
+18.00 JP¥ · +1.25%
تستخدم الأوقات اليومية المنطقة الزمنية JST. قد تتأخر بيانات السوق.
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
نطاق اليوم
السعر الحالي 1,458 JP¥
نطاق 52 أسبوعًا
السعر الحالي 1,458 JP¥
تستخدم الأوقات اليومية المنطقة الزمنية JST. قد تتأخر بيانات السوق.
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
نطاق اليوم
السعر الحالي 1,458 JP¥
نطاق 52 أسبوعًا
السعر الحالي 1,458 JP¥
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (JPY) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 579.63 مليار JPY | 586.53 مليار JPY | 558.06 مليار JPY | 538.03 مليار JPY | 467.94 مليار JPY |
| تكلفة البضاعة المباعة | 433.34 مليار JPY | 420.69 مليار JPY | 397.67 مليار JPY | 390.98 مليار JPY | 328.26 مليار JPY |
| الربح الإجمالي | 146.29 مليار JPY | 165.84 مليار JPY | 160.39 مليار JPY | 147.04 مليار JPY | 139.68 مليار JPY |
| البحث والتطوير | — | 25.93 مليار JPY | 23.39 مليار JPY | 21.88 مليار JPY | 20.74 مليار JPY |
| مصاريف البيع والمصاريف العمومية والإدارية | 104.22 مليار JPY | 78.9 مليار JPY | 74.6 مليار JPY | 77.66 مليار JPY | 68.24 مليار JPY |
| نفقات التشغيل | 104.22 مليار JPY | 104.83 مليار JPY | 97.99 مليار JPY | 99.54 مليار JPY | 88.98 مليار JPY |
| دخل الفوائد | 816 مليون JPY | 1.21 مليار JPY | 1.57 مليار JPY | 697 مليون JPY | 236 مليون JPY |
| مصاريف الفوائد | 3.2 مليار JPY | 1.98 مليار JPY | 1.67 مليار JPY | 1.43 مليار JPY | 1.36 مليار JPY |
| الاستهلاك والإطفاء | 43.34 مليار JPY | 41.37 مليار JPY | 33.7 مليار JPY | 31.58 مليار JPY | 28.2 مليار JPY |
| الدخل التشغيلي | 42.07 مليار JPY | 61.01 مليار JPY | 62.39 مليار JPY | 47.51 مليار JPY | 50.7 مليار JPY |
| صافي الدخل | 10.18 مليار JPY | 49.48 مليار JPY | 55.84 مليار JPY | 40.68 مليار JPY | 31.25 مليار JPY |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
توزيعات نقدية سنوية معدلة للسهم الواحد.
60.00 JP¥
2025 سنة كاملة+87.5% منذ 2021
2026 سنة جزئية: 65.00 JP¥
32.00 JP¥
2,021
36.00 JP¥
2,022
45.00 JP¥
2,023
55.00 JP¥
2,024
60.00 JP¥
2,025
65.00 JP¥
2,026*
* سنة تقويمية جزئية ضمن سجل توزيعات الأرباح المتاح.
| الإجراء | تاريخ الاستحقاق | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
توزيعات الأرباحالقادمة | 30 مارس 2027 | 35.00 JP¥Semi-Annual | 31 مارس 2027 | 30 مارس 2027 |
توزيعات الأرباح | 29 سبتمبر 2026 | 35.00 JP¥Semi-Annual | 30 سبتمبر 2026 | 29 سبتمبر 2026 |
توزيعات الأرباح | 30 مارس 2026 | 30.00 JP¥Semi-Annual | 31 مارس 2026 | 22 يونيو 2026 |
توزيعات الأرباح | 29 سبتمبر 2025 | 30.00 JP¥Semi-Annual | 30 سبتمبر 2025 | 2 ديسمبر 2025 |
توزيعات الأرباح | 28 مارس 2025 | 30.00 JP¥Semi-Annual | 31 مارس 2025 | 23 يونيو 2025 |
توزيعات الأرباح | 27 سبتمبر 2024 | 30.00 JP¥Semi-Annual | 30 سبتمبر 2024 | 3 ديسمبر 2024 |
استحقاق التوزيعات 30 مارس 2027
35.00 JP¥
Semi-Annual
تاريخ التسجيل 31 مارس 2027 · تاريخ الدفع 30 مارس 2027
استحقاق التوزيعات 29 سبتمبر 2026
35.00 JP¥
Semi-Annual
تاريخ التسجيل 30 سبتمبر 2026 · تاريخ الدفع 29 سبتمبر 2026
استحقاق التوزيعات 30 مارس 2026
30.00 JP¥
Semi-Annual
تاريخ التسجيل 31 مارس 2026 · تاريخ الدفع 22 يونيو 2026
استحقاق التوزيعات 29 سبتمبر 2025
30.00 JP¥
Semi-Annual
تاريخ التسجيل 30 سبتمبر 2025 · تاريخ الدفع 2 ديسمبر 2025
استحقاق التوزيعات 28 مارس 2025
30.00 JP¥
Semi-Annual
تاريخ التسجيل 31 مارس 2025 · تاريخ الدفع 23 يونيو 2025
استحقاق التوزيعات 27 سبتمبر 2024
30.00 JP¥
Semi-Annual
تاريخ التسجيل 30 سبتمبر 2024 · تاريخ الدفع 3 ديسمبر 2024
صناديق متداولة تفصح عن تعرضها لهذا السهم.
NEXT FUNDS TOPIX Exchange Traded Fund1306.T9.12 مليار0.03%35.13 ترليون JPY0.05%432.5 JP¥+0.70%
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T911.15 مليون0.04%2.36 ترليون JPY0.11%37,120 JP¥+0.05%
iShares Core TOPIX ETF1475.T804.38 مليون0.03%3.01 ترليون JPY0.05%425.6 JP¥+0.45%
iShares JPX-Nikkei 400 ETF1364.T245.24 مليون0.04%615.95 مليار JPY0.05%3,816 JP¥+0.69%
Avantis International Small Cap Value ETFAVDV50.29 مليون0.25%20.04 مليار USD0.36%108.52 US$+0.74%
Vanguard Total International Stock ETFVXUS33.14 مليون0.00%665.7 مليار USD0.05%84.82 US$+0.86%
Vanguard FTSE Developed Markets ETFVEA20.23 مليون0.01%323.8 مليار USD0.03%70.35 US$+0.70%
iShares Core MSCI EAFE ETFIEFA15.86 مليون0.01%189.47 مليار USD0.07%96.52 US$+0.68%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T
iShares Core TOPIX ETF1475.T
iShares JPX-Nikkei 400 ETF1364.T
Avantis International Small Cap Value ETFAVDV
Vanguard Total International Stock ETFVXUS
Vanguard FTSE Developed Markets ETFVEA
iShares Core MSCI EAFE ETFIEFAالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.